Concepedia

Xu Zhu

XZ

Statistics

Publications

17

Citations

588

H-Index

13

Active since

2009

Affiliations

University of Toronto(Current)

Pfizer (United States)

University at Buffalo, State University of New York

China Medical University

Chongqing Medical University

Xu Zhu is an author at University of Toronto specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2009–2025

17

Publications

17

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri et al. · The Lancet · 2025 · 151 citations · Full text

, , +8

Ultrasound triggered image-guided drug delivery to inhibit vascular reconstruction via paclitaxel-loaded microbubbles

Xu Zhu, Jun Guo, Cancan He et al. · Scientific Reports · 2016 · 57 citations · Full text

Cytokine and autoantibody patterns in acute liver failure

Jinze Li, Xu Zhu, Feng Liu et al. · Journal of Immunotoxicology · 2009 · 49 citations · Full text

Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model

Changhua Ji, Mausumee Guha, Xu Zhu et al. · Chemical Research in Toxicology · 2019 · 47 citations

, , +19

Effects of Major Transporter and Metabolizing Enzyme Gene Polymorphisms on Carbamazepine Metabolism in Chinese Patients with Epilepsy

Xu Zhu, Wenting Yun, Xiaofu Sun et al. · Pharmacogenomics · 2014 · 41 citations

Rows per page

1–5 of 17